TherapeuticsMD, Inc. (NASDAQ: TXMD) today announced that the United States Food and Drug Administration (FDA) has approved IMVEXXY (estradiol vaginal ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE